cPRIME enables endogenous mapping of genetic variant effects at RNA level
Abstract
Understanding the functional consequences of genetic variants, particularly those classified as variants of uncertain significance (VUS), is a major challenge in genomics. While variant effects at protein level are well recognized, roles in post-transcriptional regulation are increasingly appreciated. Here, we introduce cPRIME (prime editing with cDNA readout), a scalable method for assessing variant effects at RNA level. cPRIME employs prime editing to insert genetic variants into endogenous genomic loci, followed by the quantification of changes in variant frequencies at RNA (cDNA) and genomic DNA (gDNA) level. We demonstrate its effectiveness across diverse karyotypes and genomic loci and reveal that synonymous marker edits - frequently used in prime editing screens - can themselves alter RNA processing and thereby confound the interpretation of variant effects. Taken together, cPRIME provides a platform for studying the post-transcriptional consequences of genetic variants in their genomic context and establishes a framework for the functional interpretation of RNA-altering variants in cancer and other diseases.
Related
- idTAG enables programmable and physiologically faithful control of endogenous protein degradation
- A circRNA-derived IRES-like element enables programmable translational activation of the endogenous chaperone HSP90
- Distinct genetic perturbations at the endogenous Atf4 locus uncouple polyadenylation loss from transcriptional readthrough
- From conservation scores to language models: a feature engineering perspective on machine learning for genetic variant interpretation
- Saturation mutagenesis enables RAD51D clinical variant interpretation and identifies distinct biochemical functions
BibTeX
@article{kassem2026cprime,
title = {{cPRIME enables endogenous mapping of genetic variant effects at RNA level}},
author = {Ghanem El Kassem and Constanze Westphal and Marvin Doebel and Jasmine Hillmer and Tanja Seifert and Michael Boettcher},
journal = {Nature Communications},
year = {2026},
month = oct,
doi = {10.1038/s41467-026-78344-9},
url = {https://www.nature.com/articles/s41467-026-78344-9},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - cPRIME enables endogenous mapping of genetic variant effects at RNA level
AU - Ghanem El Kassem
AU - Constanze Westphal
AU - Marvin Doebel
AU - Jasmine Hillmer
AU - Tanja Seifert
AU - Michael Boettcher
PY - 2026
DA - 2026/10/15
JO - Nature Communications
DO - 10.1038/s41467-026-78344-9
UR - https://www.nature.com/articles/s41467-026-78344-9
AB - Understanding the functional consequences of genetic variants, particularly those classified as variants of uncertain significance (VUS), is a major challenge in genomics. While variant effects at protein level are well recognized, roles in post-transcriptional regulation are increasingly appreciated. Here, we introduce cPRIME (prime editing with cDNA readout), a scalable method for assessing variant effects at RNA level. cPRIME employs prime editing to insert genetic variants into endogenous genomic loci, followed by the quantification of changes in variant frequencies at RNA (cDNA) and genomic DNA (gDNA) level. We demonstrate its effectiveness across diverse karyotypes and genomic loci and reveal that synonymous marker edits - frequently used in prime editing screens - can themselves alter RNA processing and thereby confound the interpretation of variant effects. Taken together, cPRIME provides a platform for studying the post-transcriptional consequences of genetic variants in their genomic context and establishes a framework for the functional interpretation of RNA-altering variants in cancer and other diseases.
SN - 2041-1723
ER -